Literature DB >> 16763224

Respiratory syncytial virus infection reduces beta2-adrenergic responses in human airway smooth muscle.

Paul E Moore1, Gary Cunningham, Mark M Calder, Anthony D DeMatteo, Mark E Peeples, Marshall L Summar, R Stokes Peebles.   

Abstract

Although respiratory syncytial virus (RSV) is the most common cause of lower respiratory tract illness in infants, the effect of RSV on human airway smooth muscle (HASM) has not been studied. We hypothesized that RSV has direct effects on cAMP formation and beta(2)-adrenergic receptor (ADRB2) density and that ADRB2 haplotype influences this response. A recombinant green-fluorescent protein (rg) expressing RSV was used to determine whether RSV could infect cultured HASM. Influence of RSV infection on beta(2)-adrenergic responsiveness was determined by measuring differences in isoproterenol (ISO)-induced cyclic AMP (cAMP) formation, ADRB2 density, and G(i) expression in HASM cells challenged with RSV, with ultraviolet-inactivated RSV, and with mock infection. The rgRSV efficiently infected cultured HASM cells. ISO-induced cAMP formation was significantly reduced in cells infected with RSV, compared with mock-infected and ultraviolet-inactivated RSV, in a time- and concentration-dependent manner. Forskolin-induced cAMP formation and Gi expression were not altered in cells infected with RSV, suggesting that the influence of RSV on beta(2)-adrenergic relaxation was upstream of cAMP formation. ADRB2 density was reduced in cells infected with RSV, compared with mock infection, and the Arg16Gln27 ADRB2 haplotype was associated with decreased ISO-induced cAMP formation (P < 0.05) and with decreased ADRB2 density at baseline (P < 0.05). The implications of these results are that limitations of beta(2)-agonists in the treatment of any airway obstruction associated with RSV infection may be related to direct effects of RSV on HASM, and ADRB2 genotype may predict beta(2)-adrenergic responses.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16763224      PMCID: PMC2643275          DOI: 10.1165/rcmb.2005-0282OC

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN: 1044-1549            Impact factor:   6.914


  26 in total

1.  Cytokine- and virus-stimulated airway smooth muscle cells produce IL-11 and other IL-6-type cytokines.

Authors:  J A Elias; Y Wu; T Zheng; R Panettieri
Journal:  Am J Physiol       Date:  1997-09

2.  Effect of IL-1 beta on responses of cultured human airway smooth muscle cells to bronchodilator agonists.

Authors:  S A Shore; J Laporte; I P Hall; E Hardy; R A Panettieri
Journal:  Am J Respir Cell Mol Biol       Date:  1997-06       Impact factor: 6.914

3.  The effect of polymorphisms of the beta(2)-adrenergic receptor on the response to regular use of albuterol in asthma.

Authors:  E Israel; J M Drazen; S B Liggett; H A Boushey; R M Cherniack; V M Chinchilli; D M Cooper; J V Fahy; J E Fish; J G Ford; M Kraft; S Kunselman; S C Lazarus; R F Lemanske; R J Martin; D E McLean; S P Peters; E K Silverman; C A Sorkness; S J Szefler; S T Weiss; C N Yandava
Journal:  Am J Respir Crit Care Med       Date:  2000-07       Impact factor: 21.405

4.  Bronchiolitis-associated hospitalizations among US children, 1980-1996.

Authors:  D K Shay; R C Holman; R D Newman; L L Liu; J W Stout; L J Anderson
Journal:  JAMA       Date:  1999-10-20       Impact factor: 56.272

5.  Complex promoter and coding region beta 2-adrenergic receptor haplotypes alter receptor expression and predict in vivo responsiveness.

Authors:  C M Drysdale; D W McGraw; C B Stack; J C Stephens; R S Judson; K Nandabalan; K Arnold; G Ruano; S B Liggett
Journal:  Proc Natl Acad Sci U S A       Date:  2000-09-12       Impact factor: 11.205

6.  Rhinovirus-mediated changes in airway smooth muscle responsiveness: induced autocrine role of interleukin-1beta.

Authors:  H Hakonarson; C Carter; N Maskeri; R Hodinka; M M Grunstein
Journal:  Am J Physiol       Date:  1999-07

7.  Glycosaminoglycan sulfation requirements for respiratory syncytial virus infection.

Authors:  L K Hallak; D Spillmann; P L Collins; M E Peeples
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

8.  Use of regularly scheduled albuterol treatment in asthma: genotype-stratified, randomised, placebo-controlled cross-over trial.

Authors:  Elliot Israel; Vernon M Chinchilli; Jean G Ford; Homer A Boushey; Reuben Cherniack; Timothy J Craig; Aaron Deykin; Joanne K Fagan; John V Fahy; James Fish; Monica Kraft; Susan J Kunselman; Stephen C Lazarus; Robert F Lemanske; Stephen B Liggett; Richard J Martin; Nandita Mitra; Stephen P Peters; Eric Silverman; Christine A Sorkness; Stanley J Szefler; Michael E Wechsler; Scott T Weiss; Jeffrey M Drazen
Journal:  Lancet       Date:  2004 Oct 23-29       Impact factor: 79.321

Review 9.  Systematic review and meta-analysis of the association between {beta}2-adrenoceptor polymorphisms and asthma: a HuGE review.

Authors:  Ammarin Thakkinstian; Mark McEvoy; Cosetta Minelli; Peter Gibson; Bob Hancox; David Duffy; John Thompson; Ian Hall; Joel Kaufman; Ting-Fan Leung; Peter Joseph Helms; Hakon Hakonarson; Eva Halpi; Ruth Navon; John Attia
Journal:  Am J Epidemiol       Date:  2005-06-29       Impact factor: 4.897

Review 10.  Pathogenesis of respiratory syncytial virus bronchiolitis-related wheezing.

Authors:  Stelios Psarras; Nikolaos G Papadopoulos; Sebastian L Johnston
Journal:  Paediatr Respir Rev       Date:  2004       Impact factor: 2.726

View more
  8 in total

Review 1.  Targeting airway smooth muscle in airways diseases: an old concept with new twists.

Authors:  Cynthia J Koziol-White; Gautam Damera; Reynold A Panettieri
Journal:  Expert Rev Respir Med       Date:  2011-12       Impact factor: 3.772

Review 2.  Nasal potential difference to detect Na+ channel dysfunction in acute lung injury.

Authors:  R Mac Sweeney; H Fischer; D F McAuley
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2010-11-26       Impact factor: 5.464

3.  Respiratory syncytial virus induces insensitivity to beta-adrenergic agonists in mouse lung epithelium in vivo.

Authors:  Ian C Davis; Anna Xu; Zhiqian Gao; Judy M Hickman-Davis; Phillip Factor; Wayne M Sullender; Sadis Matalon
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2007-04-13       Impact factor: 5.464

4.  TLR3 activation increases chemokine expression in human fetal airway smooth muscle cells.

Authors:  Arij Faksh; Rodney D Britt; Elizabeth R Vogel; Michael A Thompson; Hitesh C Pandya; Richard J Martin; Christina M Pabelick; Y S Prakash
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2015-11-20       Impact factor: 5.464

5.  Post-infection A77-1726 blocks pathophysiologic sequelae of respiratory syncytial virus infection.

Authors:  Ian C Davis; Eduardo R Lazarowski; Fu-Ping Chen; Judy M Hickman-Davis; Wayne M Sullender; Sadis Matalon
Journal:  Am J Respir Cell Mol Biol       Date:  2007-05-31       Impact factor: 6.914

Review 6.  An overview on the RSV-mediated mechanisms in the onset of non-allergic asthma.

Authors:  Sara Manti; Giovanni Piedimonte
Journal:  Front Pediatr       Date:  2022-09-20       Impact factor: 3.569

7.  Respiratory syncytial virus induces β2-adrenergic receptor dysfunction in human airway smooth muscle cells.

Authors:  Terri J Harford; Fariba Rezaee; Manveen K Gupta; Vladimir Bokun; Sathyamangla V Naga Prasad; Giovanni Piedimonte
Journal:  Sci Signal       Date:  2021-06-01       Impact factor: 8.192

Review 8.  Epithelial sodium channels in the adult lung--important modulators of pulmonary health and disease.

Authors:  Ian C Davis; Sadis Matalon
Journal:  Adv Exp Med Biol       Date:  2007       Impact factor: 2.622

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.